Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 31.93B | 30.01B | 28.68B | 25.91B | 22.91B |
Gross Profit | 9.14B | 7.72B | 7.47B | 7.05B | 5.89B |
EBITDA | 6.23B | 5.03B | 4.77B | 4.60B | 3.67B |
Net Income | 3.13B | 2.38B | 2.12B | 1.73B | 1.28B |
Balance Sheet | |||||
Total Assets | 59.17B | 56.90B | 50.01B | 47.31B | 45.15B |
Cash, Cash Equivalents and Short-Term Investments | 15.87B | 14.83B | 12.51B | 12.85B | 13.17B |
Total Debt | 3.37B | 3.40B | 3.42B | 3.77B | 4.00B |
Total Liabilities | 11.80B | 11.74B | 10.20B | 10.48B | 10.18B |
Stockholders Equity | 40.91B | 39.22B | 34.33B | 31.81B | 30.47B |
Cash Flow | |||||
Free Cash Flow | 1.94B | 3.13B | 1.01B | 460.77M | 3.31B |
Operating Cash Flow | 3.30B | 4.02B | 1.96B | 1.40B | 4.53B |
Investing Cash Flow | -1.79B | -1.35B | -2.13B | -1.27B | -1.70B |
Financing Cash Flow | -856.44M | -716.78M | -887.99M | -701.62M | -349.02M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | ¥11.69B | 9.16 | 3.09% | 9.24% | 12.50% | ||
75 Outperform | ¥14.05B | 12.21 | 3.70% | 0.73% | 10.12% | ||
71 Outperform | ¥25.62B | 14.77 | 5.30% | -3.07% | -44.51% | ||
69 Neutral | ¥23.43B | 8.24 | 3.66% | 5.63% | 6.00% | ||
58 Neutral | HK$18.25B | 4.78 | -7.57% | 3.74% | -4.22% | -42.54% | |
56 Neutral | ¥3.11B | 831.46 | 2.96% | -1.64% | -98.70% | ||
54 Neutral | ¥1.29B | 16.91 | 2.32% | 2.34% | ― |